D5W Administration Guidelines

Primary Clinical Indications

The American Academy of Pediatrics and other medical societies recommend D5W for patients with nephrogenic diabetes insipidus who must fast for prolonged periods (>4 hours), such as before anesthesia, administered at usual maintenance rates 1
In patients with nephrogenic diabetes insipidus, D5W provides no renal osmotic load, which typically decreases urine volume considerably, though blood glucose monitoring is crucial as glucose infusion can paradoxically cause hyperglycemia with subsequent osmotic diuresis 1
The National Kidney Foundation recommends D5W as the preferred fluid for treating hypernatremic dehydration in patients with nephrogenic diabetes insipidus because salt-containing solutions should be avoided due to their large renal osmotic load 2
The American Diabetes Association recommends that in diabetic ketoacidosis, fluid should be changed to 5% dextrose with 0.45-0.75% saline once serum glucose reaches 250 mg/dL 3

The American Academy of Pediatrics recommends that hypotonic maintenance fluids, including D5 0.45% NaCl, are associated with increased risk of hospital-acquired hyponatremia compared to isotonic fluids 5, 6
The American Heart Association and other medical societies warn that hyponatremic encephalopathy is a medical emergency that can be fatal or lead to irreversible brain injury if inadequately treated 5, 6

The American Society of Health-System Pharmacists recommends that D5W serves as a vehicle for specific medication infusions, including dopamine and epinephrine, and requires regular control of blood glucose 4
The Endocrine Society recommends that blood glucose levels should be monitored when using any dextrose-containing solution, especially in diabetic patients 4
The National Institute of Diabetes and Digestive and Kidney Diseases recommends that the induced change in serum osmolality should not exceed 3 mOsm/kg H₂O per hour when treating hypernatremia 2, 3